CareDx(CDNA)
搜索文档
CareDx(CDNA) - 2021 Q3 - Earnings Call Transcript
2021-10-29 10:49
CareDx, Inc. (NASDAQ:CDNA) Q3 2021 Earnings Conference Call October 28, 2021 4:30 PM ET Company Participants Ian Cooney - Investor Relations Reg Seeto - President and Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Matt Sykes - Goldman Sachs Alex Nowak - Craig-Hallum Capital Group Mark Massaro - BTIG Andrew Cooper - Raymond James Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the CareDx, Incorporated Third Quarter 2021 Earnings Conference Call. [Ope ...
CareDx(CDNA) - 2021 Q3 - Quarterly Report
2021-10-28 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-365 ...
CareDx(CDNA) - 2021 Q2 - Earnings Call Transcript
2021-07-30 22:15
CareDX, Inc. (NASDAQ:CDNA) Q2 2021 Earnings Conference Call July 29, 2021 4:30 PM ET Company Participants Ian Cooney - Investor Relations Reg Seeto - President and Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Andrew Cooper - Raymond James Matt Sykes - Goldman Sachs Steven Mah - Piper Sandler Brandon Couillard - Jefferies Alex Nowak - Craig-Hallum Capital Group Mark Massaro - BTIG Yi Chen - H.C. Wainwright Operator Greetings, and welcome to the CareDx, Inc. Sec ...
CareDx(CDNA) - 2021 Q2 - Quarterly Report
2021-07-29 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 __ ...
CareDx(CDNA) - 2021 Q1 - Earnings Call Presentation
2021-05-11 07:41
The Allo-Transplantation Company Focused on better outcomes through personalized transplant surveillance May 2021 Allo-transplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species Dx® Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements r ...
CareDx(CDNA) - 2021 Q1 - Earnings Call Transcript
2021-05-06 09:08
CareDx, Inc. (NASDAQ:CDNA) Q1 2021 Earnings Conference Call May 5, 2021 4:30 PM ET Company Participants Greg Chodaczek - Managing Director, Gilmartin Group Reginald Seeto - President and Chief Executive Officer Ankur Dhingra - Chief Financial Officer Conference Call Participants Brandon Couillard - Jefferies Andrew Cooper - Raymond James Alex Nowak - Craig-Hallum Capital Group Steven Mah - Piper Sandler Operator Greetings, and welcome to the CareDX, Inc. First Quarter 2021 Earnings Conference Call. At this ...
CareDx(CDNA) - 2021 Q1 - Quarterly Report
2021-05-05 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________________________________ FORM 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-36536 _ ...
CareDx(CDNA) - 2020 Q4 - Earnings Call Presentation
2021-02-27 03:37
The Allo-Transplantation Company Focused on better outcomes through personalized transplant surveillance February 2021 Allo-transplant (allo- meaning "other" in Greek) is the transplantation of cells, tissues or organs to a recipient from a genetically non-identical donor of the same species Safe Harbor Statement These slides and the accompanying oral presentation contain forward-looking statements. All statements other than statements of historical fact contained in this presentation, including statements ...
CareDx(CDNA) - 2020 Q4 - Earnings Call Transcript
2021-02-25 11:38
Start Time: 16:30 January 1, 0000 5:13 PM ET CareDx, Inc. (NASDAQ:CDNA) Q4 2020 Earnings Conference Call February 24, 2021, 16:30 PM ET Company Participants Reginald Seeto - President and CEO Marcel Konrad - CFO Sham Dholakia - SVP, Medical Affairs and Clinical Operations Greg Chodaczek - Managing Director Conference Call Participants Matthew Andrews - Jefferies Rachel Vatnsdal - Piper Sandler Alex Nowak - Craig-Hallum Capital Group Andrew Cooper - Raymond James Sung-Ji Nam - BTIG Boobalan Pachaiyappan - H. ...
CareDx(CDNA) - 2020 Q4 - Annual Report
2021-02-24 00:00
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ________________________________________________________________________________________________________ Form 10-K ________________________________________________________________________________________________________ (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF TH ...